Ketogenic Diet for Fatty Liver with Scarring
Part of Digestive system clinical trials.
This study tests whether a special high-fat, low-carb diet (ketogenic diet) can help people with MASLD-related liver scarring that hasn't yet caused major complications. It aims to see if this diet can improve liver health and reduce future risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with MASLD (fatty liver disease related to metabolism) and have liver scarring (cirrhosis) that is still well-controlled (compensated).
- You do not have other liver diseases like hepatitis B or C, autoimmune hepatitis, or Wilson's disease.
- You do not drink heavily (more than about 2 drinks per day for women or 3 for men), and you haven't lost a lot of weight in the past 6 months.
- You are not pregnant or breastfeeding, and you don't have conditions like type 1 diabetes, severe heart problems, or advanced kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study tests whether a traditional Chinese herbal medicine (CXD) combined with a restrictive ketogenic diet can reduce fat buildup in the liver. You may be a good fit if you have fatty liver disease and are interested in trying this combination approach.
This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This trial tests whether a digital diet and exercise program can reduce liver scarring in people with MASLD (fatty liver disease not caused by alcohol). You would use an app on your smartphone to follow the program at home.
Hear when a new Steatosis of Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.